Last reviewed · How we verify
NCT02988531
Validation of PET-MRI for Cardiovascular Disease
NA trial testing PET/MR scan in MRI in 20 participants. Completed in 7 December 2017.
7 December 2017
Quick facts
| Lead sponsor | University of Edinburgh |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 20 |
| Start date | 9 February 2017 |
| Primary completion | 7 December 2017 |
| Estimated completion | 7 December 2017 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- PET/MR scan
Conditions studied
- MRI — all drugs for MRI →
- PET Scan — all drugs for PET Scan →
- Positron-Emission Tomography — all drugs for Positron-Emission Tomography →
- Cardiovascular Disease — all drugs for Cardiovascular Disease →
Sponsor
University of Edinburgh
Who can join
50 and older, any sex, with MRI or PET Scan. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine whether PET-MRI can obtain comparable images to PET-CT in those with coronary artery disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Aortic valve stenosis-multimodality assessment with PET/CT and PET/MRI.
Tzolos E, Andrews JP, Dweck MR. · · 2020 · cited 20× · PMID 31647323 · DOI 10.1259/bjr.20190688
Verify or expand the search:
- PubMed search for NCT02988531
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PET/MR scan
Trials testing the same drug.
- NCT04154280 — Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer · NA · unknown
- NCT04154241 — Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor · NA · unknown
- NCT04152928 — Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities · NA · unknown
- NCT04154228 — Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI · NA · unknown
- NCT04158414 — Applying PET/MR in Oncology - a Prospective Project · NA · unknown
Other recruiting trials for MRI
Currently open trials in the same condition.
- NCT07135401 — Optimizing Liver MRI Using Breath-Holding With and Without Oxygen · NA · recruiting
- NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
- NCT06946771 — Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Pros · recruiting
- NCT06755697 — Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Manage · NA · recruiting
- NCT07173140 — Renal Tumour Imaging Using MRI · NA · active not recruiting
Other University of Edinburgh trials
Trials by the same sponsor.
- NCT07341126 — Use of a Novel Camera to Check the Bowel After Polyp or Tumour Removal · not yet recruiting
- NCT07523997 — Imaging of Endometriosis With Total-body PET-CT (PET-Endo) · not yet recruiting
- NCT07430540 — Optimising Colorectal Cancer Patient Pathways · NA · not yet recruiting
- NCT07430527 — Secondary Care Colorectal Cancer Pathway Review · not yet recruiting
- NCT07436026 — Latin America Network for Primary Palliative Care · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02988531 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Edinburgh
- Last refreshed: 21 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02988531.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing